UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061382
Receipt number R000070097
Scientific Title Process Evaluation of an Online Imagery Rescripting Intervention for School Refusal Children with Distressing School Experiences
Date of disclosure of the study information 2026/08/01
Last modified on 2026/04/26 22:40:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Process Evaluation of an Online Imagery Rescripting Intervention for School Refusal Children with Distressing School Experiences

Acronym

Online Imagery Rescripting Intervention for School Refusal Children

Scientific Title

Process Evaluation of an Online Imagery Rescripting Intervention for School Refusal Children with Distressing School Experiences

Scientific Title:Acronym

Online Imagery Rescripting Intervention for School Refusal Children

Region

Japan


Condition

Condition

Individuals with school refusal (more than 30 days of non-attendance in the past year)

Classification by specialty

Psychiatry Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to comprehensively examine the feasibility and safety of an online support program, Imagery Rescripting, for students who have become school-refusing due to distressing school experiences.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

recruitment rate of eligible participants, retention rate, adherence rate of sessions and Presence or Absence of Adverse Event

Key secondary outcomes

for participants
Acceptability of Intervention Measure
Visual Analog Scale for the distress associated with the image
vividness of image
frequency of image for 1 week
Visual Analog Scale for the emotions associated with the image
credibility of the meaning associated with the image
attendance rate
PTSD Checklist for DSM-5
Patient Health Questionnaire-A
Generalized Anxiety Disorder-7
EQ-5D-Y-5L
Heart Rate Variability
satisfaction
Qualitative feedback
for therapist
Fidelity
Intervention Appropriateness Measure
Feasibility of Intervention Measure
Clinical Global Impression
feedback
for parents
cost-effectiveness
Qualitative feedback


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Other

Interventions/Control_1

Online Imagery Rescripting

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

10 years-old <=

Age-upper limit

15 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Children aged 10 to 15 years (from 5th grade of elementary school to 3rd grade of junior high school)
2. Individuals experiencing school refusal (defined as absence from school for 30 or more days in the past year) associated with distressing school experiences
3. A distress level of 30 or higher (on a screening measure) related to school-related distressing experiences
4. Provision of informed consent from both the participant and their parent/guardian
5. Currently receiving care at the University of the Ryukyus Hospital
6. Access to the internet (via computer, smartphone, or tablet)
7. Ability to participate in the online program once a week for seven consecutive weeks
8. Availability of a parent/guardian at home or reachable immediately during sessions for emergency support
9. Native Japanese speakers who are able to understand explanations in Japanese and provide informed consent voluntarily

Key exclusion criteria

1. Individuals with a diagnosis of psychotic disorders (including schizophrenia), intellectual disability, bipolar I disorder, eating disorders, substance use disorders, or personality disorders
2. Individuals with a history of neurological injury (e.g., cerebrovascular disease, brain tumor, or traumatic brain injury)
3. Individuals at imminent risk of suicide (defined as a score of 2 or higher on Item 9 of the PHQ-A)
4. Individuals whose type or dosage of prescribed medication for mental health problems has been changed within the past two months at the time of program entry, or who are expected to have changes during the study period
5. Individuals who plan to receive other psychological interventions during the program (including school counseling)
6. Individuals with whom it is difficult to maintain contact
7. Individuals deemed unsuitable for safe participation in this study by the principal investigator or study staff

Target sample size

5


Research contact person

Name of lead principal investigator

1st name Mirai
Middle name
Last name Miyoshi

Organization

university of the ryukyus

Division name

Department of mental health nursing, faculty of medicine

Zip code

901-2720

Address

1076 Kiyuna, Ginowan City, Okinawa, Japan

TEL

098-894-5203

Email

miyoshi_ft5k@cs.u-ryukyu.ac.jp


Public contact

Name of contact person

1st name Mirai
Middle name
Last name Miyoshi

Organization

university of the ryukyus

Division name

Department of mental health nursing, faculty of medicine

Zip code

901-2720

Address

1076 Kiyuna, Ginowan City, Okinawa, Japan

TEL

098-894-5203

Homepage URL


Email

miyoshi_ft5k@cs.u-ryukyu.ac.jp


Sponsor or person

Institute

university of the ryukyus

Institute

Department

Personal name



Funding Source

Organization

The Telecommunications Advancement Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

japan


Other related organizations

Co-sponsor

chiba university

Name of secondary funder(s)



IRB Contact (For public release)

Organization

University of the Ryukyus Hospital Clinical Research Support Center

Address

1076 Kiyuna, Ginowan City, Okinawa, Japan

Tel

098-894-1455

Email

creemryukyu@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

琉球大学病院


Other administrative information

Date of disclosure of the study information

2026 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 04 Month 26 Day

Date of IRB


Anticipated trial start date

2026 Year 08 Month 01 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 04 Month 26 Day

Last modified on

2026 Year 04 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070097